# RenX Enterprises Corp.: financial statements, quarterly

RENX · Nasdaq · CIK 1959023 · [Utilities](/sectors/utilities.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/renx.md) · [Financials](/companies/renx/financials.md) · [Filings](/companies/renx/filings.md) · [Insiders](/companies/renx/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/renx/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | not reported | not reported | [49.8](/filings/0001213900-25-044332.md) | [42.2](/filings/0001213900-25-076933.md) | [81.2](/filings/0001213900-25-110837.md) | [34.4 d](/filings/0001213900-26-037999.md) | [18.2](/filings/0001213900-26-057186.md) | [1,403](/filings/0001213900-26-089068.md) | [3,516](/filings/0001213900-25-110837.md) | [3,284 d](/filings/0001213900-26-037999.md) | [3,958](/filings/0001213900-26-057186.md) | [4,256](/filings/0001213900-26-089068.md) |
| Cost of revenue | $k | not reported | not reported | [28.1](/filings/0001213900-25-044332.md) | not reported | not reported | not reported | [11.8](/filings/0001213900-26-057186.md) | [858](/filings/0001213900-26-089068.md) | [2,607](/filings/0001213900-25-110837.md) | [2,353 d](/filings/0001213900-26-037999.md) | [2,626](/filings/0001213900-26-057186.md) | [2,898](/filings/0001213900-26-089068.md) |
| Gross profit | $k | not reported | not reported | [49.8](/filings/0001213900-25-044332.md) | [42.2](/filings/0001213900-25-076933.md) | [81.2](/filings/0001213900-25-110837.md) | [(148) d](/filings/0001213900-26-037999.md) | [6.4](/filings/0001213900-26-057186.md) | [545](/filings/0001213900-26-089068.md) | [909](/filings/0001213900-25-110837.md) | [931 d](/filings/0001213900-26-037999.md) | [1,332](/filings/0001213900-26-057186.md) | [1,357](/filings/0001213900-26-089068.md) |
| Operating income | $k | [(584)](/filings/0001213900-24-098505.md) | [(1,222) d](/filings/0001213900-25-026215.md) | [(2,502)](/filings/0001213900-25-044332.md) | [(903)](/filings/0001213900-25-076933.md) | [(1,391)](/filings/0001213900-25-110837.md) | [(1,763) d](/filings/0001213900-26-037999.md) | [(1,264)](/filings/0001213900-26-057186.md) | [(4,934)](/filings/0001213900-26-089068.md) | [(2,332)](/filings/0001213900-25-110837.md) | [(3,920) d](/filings/0001213900-26-037999.md) | [(2,769)](/filings/0001213900-26-057186.md) | [(2,996)](/filings/0001213900-26-089068.md) |
| Interest expense | $k | [340](/filings/0001213900-23-086886.md) | [363 d](/filings/0001213900-24-028274.md) | [566](/filings/0001213900-24-043558.md) | [1,066](/filings/0001213900-24-068958.md) | [951](/filings/0001213900-25-110837.md) | [891 d](/filings/0001213900-26-037999.md) | [955](/filings/0001213900-26-057186.md) | [830](/filings/0001213900-26-089068.md) | [2,004](/filings/0001213900-25-110837.md) | [1,476 d](/filings/0001213900-26-037999.md) | [1,332](/filings/0001213900-26-057186.md) | [2,809](/filings/0001213900-26-089068.md) |
| Net income | $k | [(924)](/filings/0001213900-24-098505.md) | [(1,585) d](/filings/0001213900-25-026215.md) | [(3,068)](/filings/0001213900-25-044332.md) | [(1,969)](/filings/0001213900-25-076933.md) | [(2,342)](/filings/0001213900-25-110837.md) | [(1,530) d](/filings/0001213900-26-037999.md) | [(2,180)](/filings/0001213900-26-057186.md) | [(5,724)](/filings/0001213900-26-089068.md) | [(4,350)](/filings/0001213900-25-110837.md) | [(3,703) d](/filings/0001213900-26-037999.md) | [(9,329)](/filings/0001213900-26-057186.md) | [(8,019)](/filings/0001213900-26-089068.md) |
| Diluted EPS | $ per share | [(11.32)](/filings/0001213900-24-098505.md) | not reported | [(5.17)](/filings/0001213900-25-044332.md) | [(0.13)](/filings/0001213900-25-076933.md) | [(2.61)](/filings/0001213900-25-110837.md) | not reported | [(21.68)](/filings/0001213900-26-057186.md) | [(45.90)](/filings/0001213900-26-089068.md) | [(1.12)](/filings/0001213900-25-110837.md) | not reported | [(4.87)](/filings/0001213900-26-057186.md) | [(3.08)](/filings/0001213900-26-089068.md) |
| Basic EPS | $ per share | [(11.32)](/filings/0001213900-24-098505.md) | not reported | [(5.17)](/filings/0001213900-25-044332.md) | [(0.13)](/filings/0001213900-25-076933.md) | [(2.61)](/filings/0001213900-25-110837.md) | not reported | [(21.68)](/filings/0001213900-26-057186.md) | [(45.90)](/filings/0001213900-26-089068.md) | [(1.12)](/filings/0001213900-25-110837.md) | not reported | [(4.87)](/filings/0001213900-26-057186.md) | [(3.08)](/filings/0001213900-26-089068.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | period not labelled (2024-11-13) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [0.0](/filings/0001213900-24-098505.md) | [0.1](/filings/0001213900-24-043558.md) | [0.0](/filings/0001213900-24-068958.md) | [0.0](/filings/0001213900-24-098505.md) | [0.4](/filings/0001213900-25-026215.md) | [0.2](/filings/0001213900-26-037999.md) | not reported | not reported | not reported | [0.1](/filings/0001213900-26-089068.md) | [0.5](/filings/0001213900-26-057186.md) | [2.2](/filings/0001213900-26-089068.md) |
| Current assets | $m | [0.2](/filings/0001213900-25-026215.md) | [0.5](/filings/0001213900-24-043558.md) | [1.0](/filings/0001213900-24-068958.md) | [0.8](/filings/0001213900-24-098505.md) | not reported | [1.8](/filings/0001213900-26-037999.md) | [5.7](/filings/0001213900-25-044332.md) | [3.6](/filings/0001213900-25-076933.md) | [3.3](/filings/0001213900-25-110837.md) | [2.6](/filings/0001213900-26-089068.md) | [3.2](/filings/0001213900-26-057186.md) | [5.8](/filings/0001213900-26-089068.md) |
| Total assets | $m | [9.6](/filings/0001213900-25-026215.md) | [11.8](/filings/0001213900-25-044332.md) | [12.7](/filings/0001213900-24-068958.md) | [13.0](/filings/0001213900-24-098505.md) | not reported | [12.8](/filings/0001213900-26-037999.md) | [13.1](/filings/0001213900-26-057186.md) | [39.1](/filings/0001213900-26-089068.md) | [38.4](/filings/0001213900-25-110837.md) | [35.5](/filings/0001213900-26-089068.md) | [35.7](/filings/0001213900-26-057186.md) | [38.7](/filings/0001213900-26-089068.md) |
| Current liabilities | $m | [7.7](/filings/0001213900-25-026215.md) | [8.3](/filings/0001213900-24-043558.md) | [9.7](/filings/0001213900-24-068958.md) | [10.4](/filings/0001213900-24-098505.md) | not reported | [10.4](/filings/0001213900-26-037999.md) | [12.0](/filings/0001213900-25-044332.md) | [30.4](/filings/0001213900-25-076933.md) | [32.6](/filings/0001213900-25-110837.md) | [21.6](/filings/0001213900-26-089068.md) | [30.0](/filings/0001213900-26-057186.md) | [24.0](/filings/0001213900-26-089068.md) |
| Total liabilities | $m | [7.7](/filings/0001213900-25-026215.md) | [9.3](/filings/0001213900-24-043558.md) | [10.6](/filings/0001213900-24-068958.md) | [12.2](/filings/0001213900-24-098505.md) | not reported | [11.9](/filings/0001213900-26-037999.md) | [12.8](/filings/0001213900-25-044332.md) | [34.7](/filings/0001213900-25-076933.md) | [36.4](/filings/0001213900-25-110837.md) | [31.1](/filings/0001213900-26-089068.md) | [34.5](/filings/0001213900-26-057186.md) | [31.7](/filings/0001213900-26-089068.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | [1.5](/filings/0001213900-26-037999.md) | not reported | [3.0](/filings/0001213900-25-076933.md) | [2.5](/filings/0001213900-25-110837.md) | [8.2](/filings/0001213900-26-057186.md) | [3.3](/filings/0001213900-26-057186.md) | [6.6](/filings/0001213900-26-089068.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | [8.4](/filings/0001213900-26-037999.md) | not reported | [22.2](/filings/0001213900-25-076933.md) | [21.9](/filings/0001213900-25-110837.md) | [12.5](/filings/0001213900-26-057186.md) | [21.7](/filings/0001213900-26-057186.md) | [16.6](/filings/0001213900-26-089068.md) |
| Short-term borrowings | $m | [6.8](/filings/0001213900-25-026215.md) | [6.8](/filings/0001213900-24-043558.md) | [8.4](/filings/0001213900-24-068958.md) | [8.2](/filings/0001213900-24-098505.md) | not reported | [8.4](/filings/0001213900-26-037999.md) | [8.7](/filings/0001213900-25-044332.md) | [16.7](/filings/0001213900-25-076933.md) | [16.4](/filings/0001213900-25-110837.md) | [7.0](/filings/0001213900-26-089068.md) | [16.1](/filings/0001213900-26-057186.md) | [16.1](/filings/0001213900-26-089068.md) |
| Shareholders' equity | $m | [1.9](/filings/0001213900-24-068958.md) | [2.6](/filings/0001213900-24-068958.md) | [2.0](/filings/0001213900-24-068958.md) | [0.8](/filings/0001213900-25-110837.md) | not reported | [0.9](/filings/0001213900-26-089068.md) | [0.3](/filings/0001213900-26-089068.md) | [4.5](/filings/0001213900-26-089068.md) | [2.0](/filings/0001213900-25-110837.md) | [4.4](/filings/0001213900-26-089068.md) | [1.2](/filings/0001213900-26-089068.md) | [7.0](/filings/0001213900-26-089068.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue, us-gaap:Cash
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity, us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(2,263) d](/filings/0001213900-24-098505.md) | [4.7 d](/filings/0001213900-25-026215.md) | [(694)](/filings/0001213900-25-044332.md) | [(577) d](/filings/0001213900-24-068958.md) | [(275) d](/filings/0001213900-24-098505.md) | [(1,055) d](/filings/0001213900-25-026215.md) | [(552)](/filings/0001213900-26-057186.md) | [628 d](/filings/0001213900-26-089068.md) | [(501) d](/filings/0001213900-25-110837.md) | [(6,843) d](/filings/0001213900-26-037999.md) | [(2,016)](/filings/0001213900-26-057186.md) | [(3,088) d](/filings/0001213900-26-089068.md) |
| Capital expenditure | $k | not reported | [0.0 d](/filings/0001213900-25-026215.md) | [32.0](/filings/0001213900-25-044332.md) | [(31.0) d](/filings/0001213900-24-068958.md) | [0.0 d](/filings/0001213900-24-098505.md) | [2.5 d](/filings/0001213900-26-037999.md) | not reported | not reported | not reported | not reported | [533](/filings/0001213900-26-057186.md) | [1,213 d](/filings/0001213900-26-089068.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities, us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | period not labelled (2022-09-30) | period not labelled (2023-03-31) | period not labelled (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [0.0](/filings/0001213900-23-086886.md) | [0.0](/filings/0001213900-24-043558.md) | [0.0](/filings/0001213900-24-068958.md) | [0.1](/filings/0001213900-24-098505.md) | [0.6](/filings/0001213900-25-044332.md) | [15.4](/filings/0001213900-25-076933.md) | [0.9](/filings/0001213900-25-110837.md) | [0.1](/filings/0001213900-26-057186.md) | [0.1](/filings/0001213900-26-089068.md) | [3.9](/filings/0001213900-25-110837.md) | [1.9](/filings/0001213900-26-057186.md) | [2.6](/filings/0001213900-26-089068.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 2,646,209 at 2026-08-13, from the cover of the [10-Q filed 2026-08-13](/filings/0001213900-26-089068.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.